COFCO Capital Holdings Co., Ltd. (002423.SZ)
CNY 14.29
(0.0%)
CNY 14.29
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 22.5 Billion CNY | 117.48% |
| 2022 | 9.36 Billion CNY | 0.57% |
| 2021 | 9.3 Billion CNY | 8.25% |
| 2020 | 8.59 Billion CNY | 31.77% |
| 2019 | 6.52 Billion CNY | 3504.2% |
| 2018 | 181.07 Million CNY | -13.25% |
| 2017 | 208.72 Million CNY | 20.48% |
| 2016 | 173.24 Million CNY | -23.42% |
| 2015 | 226.21 Million CNY | 9.76% |
| 2014 | 206.09 Million CNY | -9.9% |
| 2013 | 228.74 Million CNY | -3.07% |
| 2012 | 235.97 Million CNY | -1.81% |
| 2011 | 240.32 Million CNY | 7.77% |
| 2010 | 222.98 Million CNY | -8.17% |
| 2009 | 242.82 Million CNY | 20.69% |
| 2008 | 201.2 Million CNY | 17.5% |
| 2007 | 171.23 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 706.13 Million CNY | 8.74% |
| 2024 Q1 | 649.35 Million CNY | -96.81% |
| 2024 Q3 | 5.58 Billion CNY | 626.1% |
| 2023 FY | 20.35 Billion CNY | 117.48% |
| 2023 Q3 | 3.44 Billion CNY | -10.6% |
| 2023 Q4 | 20.35 Billion CNY | 491.15% |
| 2023 Q2 | 3.85 Billion CNY | 10.08% |
| 2023 Q1 | 3.49 Billion CNY | 62.35% |
| 2022 Q4 | 2.15 Billion CNY | 16.18% |
| 2022 Q3 | 1.85 Billion CNY | -20.37% |
| 2022 Q2 | 2.32 Billion CNY | -22.95% |
| 2022 Q1 | 3.02 Billion CNY | 62.79% |
| 2022 FY | 9.36 Billion CNY | 0.57% |
| 2021 FY | 9.3 Billion CNY | 8.25% |
| 2021 Q4 | 1.85 Billion CNY | -13.79% |
| 2021 Q2 | 2.34 Billion CNY | -20.69% |
| 2021 Q1 | 2.95 Billion CNY | 51.29% |
| 2021 Q3 | 2.15 Billion CNY | -8.07% |
| 2020 FY | 8.59 Billion CNY | 31.77% |
| 2020 Q3 | 2.05 Billion CNY | -1.08% |
| 2020 Q2 | 2.07 Billion CNY | -17.52% |
| 2020 Q1 | 2.51 Billion CNY | 35.67% |
| 2020 Q4 | 1.95 Billion CNY | -4.9% |
| 2019 Q3 | 1.65 Billion CNY | 16.24% |
| 2019 FY | 6.52 Billion CNY | 3504.2% |
| 2019 Q1 | 1.64 Billion CNY | 2085.8% |
| 2019 Q2 | 1.42 Billion CNY | -13.24% |
| 2019 Q4 | 1.85 Billion CNY | 11.99% |
| 2018 FY | 181.07 Million CNY | -13.25% |
| 2018 Q4 | 75.15 Million CNY | 80.61% |
| 2018 Q3 | 41.61 Million CNY | 8.51% |
| 2018 Q2 | 38.34 Million CNY | 47.76% |
| 2018 Q1 | 25.95 Million CNY | -66.03% |
| 2017 Q4 | 76.39 Million CNY | 28.3% |
| 2017 FY | 208.72 Million CNY | 20.48% |
| 2017 Q1 | 30.89 Million CNY | -2.79% |
| 2017 Q2 | 41.89 Million CNY | 35.62% |
| 2017 Q3 | 59.53 Million CNY | 42.11% |
| 2016 Q2 | 49.26 Million CNY | 31.01% |
| 2016 FY | 173.24 Million CNY | -23.42% |
| 2016 Q4 | 31.78 Million CNY | -41.79% |
| 2016 Q3 | 54.59 Million CNY | 10.83% |
| 2016 Q1 | 37.6 Million CNY | -50.91% |
| 2015 FY | 226.21 Million CNY | 9.76% |
| 2015 Q1 | 40.32 Million CNY | -39.81% |
| 2015 Q2 | 48.37 Million CNY | 19.97% |
| 2015 Q3 | 60.9 Million CNY | 25.89% |
| 2015 Q4 | 76.6 Million CNY | 25.77% |
| 2014 Q2 | 50.8 Million CNY | 25.78% |
| 2014 FY | 206.09 Million CNY | -9.9% |
| 2014 Q3 | 47.9 Million CNY | -5.69% |
| 2014 Q1 | 40.39 Million CNY | -44.73% |
| 2014 Q4 | 66.99 Million CNY | 39.83% |
| 2013 Q2 | 45.66 Million CNY | 0.15% |
| 2013 Q1 | 45.6 Million CNY | -21.78% |
| 2013 FY | 228.74 Million CNY | -3.07% |
| 2013 Q4 | 73.07 Million CNY | 13.48% |
| 2013 Q3 | 64.39 Million CNY | 41.0% |
| 2012 Q2 | 66.74 Million CNY | 23.79% |
| 2012 FY | 235.97 Million CNY | -1.81% |
| 2012 Q4 | 58.29 Million CNY | 2.23% |
| 2012 Q3 | 57.02 Million CNY | -14.56% |
| 2012 Q1 | 53.91 Million CNY | -44.09% |
| 2011 Q2 | 49.51 Million CNY | 0.91% |
| 2011 Q1 | 49.07 Million CNY | -44.21% |
| 2011 FY | 240.32 Million CNY | 7.77% |
| 2011 Q3 | 45.31 Million CNY | -8.5% |
| 2011 Q4 | 96.42 Million CNY | 112.81% |
| 2010 FY | 222.98 Million CNY | -8.17% |
| 2010 Q1 | 41.35 Million CNY | -34.64% |
| 2010 Q2 | 46.03 Million CNY | 11.3% |
| 2010 Q3 | 47.64 Million CNY | 3.51% |
| 2010 Q4 | 87.95 Million CNY | 84.58% |
| 2009 Q3 | 54.59 Million CNY | -23.35% |
| 2009 Q1 | 53.72 Million CNY | 0.0% |
| 2009 Q2 | 71.23 Million CNY | 32.59% |
| 2009 FY | 242.82 Million CNY | 20.69% |
| 2009 Q4 | 63.28 Million CNY | 15.91% |
| 2008 FY | 201.2 Million CNY | 17.5% |
| 2007 FY | 171.23 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Hubei Biocause Pharmaceutical Co., Ltd. | 50.11 Billion CNY | 55.096% |